That compares to 19 percent
for pharmaceutical development, and 9 percent for computers and electronics.
«Physicists bring order to liquid droplets, offering promise
for pharmaceutical development.»
Not exact matches
Kim co-founded VGX
Pharmaceuticals about 15 years ago, after working in vaccine
development for Merck.
Valeant's apparent lack of interest in R&D has drawn concern from some analysts and industry observers, who say research and
development is the most important expenditure
for pharmaceutical companies.
Billionaire medical magnate George Yancopoulos, the co-founder of Regeneron
Pharmaceuticals (regn), told Bloomberg that it's time
for the country to «make some decisions about what to invest in,» arguing
for more emphasis on health and less on tech
development.
In addition, CMMB's volunteer program provides medical and business know - how
for community
development and engages with the
pharmaceutical industry to help meet the needs of the poor around the world.
Agios
Pharmaceuticals shares plunged more than 18 percent after the company discontinued
development of an experimental drug
for rare blood disorder due to side effects seen in a study.
The takeover interest in Tesaro underscores the
pharmaceutical industry's strong appetite
for the acquisition of biotechnology companies with promising medicines under
development in lucrative sectors such as cancer treatment.
In healthcare, Pfizer and other
pharmaceutical companies have lined up one - off funding
for the
development of specific products, matching their capital needs with the risk preferences and expertise of individual investors.
For health plans, that means gathering input from clinicians, actuaries, claims departments,
pharmaceutical benefits managers, and countless other functions, in the
development of a high - quality product that is not only tailored to suit the varied health care needs of today's consumer, but is also affordable.
What looks like a bubble at first glance can be viewed as a long - term strategy
for funding drug
development, one that involves private funds,
pharmaceutical companies and the public markets, along with a good deal of risk — and, sometimes, high reward.
They often license promising drugs to bigger
pharmaceutical companies, which help pay
for development and become responsible
for making sales.
With the
development of smarter packaging, this specialist
for secondary packaging in the pharma /
pharmaceutical and healthcare industry meets the needs of increased digitalisation on the e-health market and the growing interest in interactive packaging solutions.
Main activities of Stork Food & Dairy Systems are the
development, production and supply of integrated processing and filling lines
for the dairy, juice, food processing and
pharmaceutical (neutraceutical) industries.
Since its foundation in 1946, Taiyo has established itself as a leader in the
development and production of emulsifiers, stabilizers, egg and tea based ingredients, and highly functional ingredients
for the food and
pharmaceutical industries.
METTLER TOLEDO is also one of the top three providers of various related measurement technologies as well as a leading vendor of systems
for automated
pharmaceutical research and the
development of active ingredients.
Development of a consistent dialogue regarding Australia's competitive positioning
for niche high - value
pharmaceutical manufacturing.
With the recent Capsugel acquisition, Lonza now offers products and services from the custom
development and manufacturing of active
pharmaceutical ingredients to innovative dosage forms
for the pharma and consumer health and nutrition industries.
He was formerly employed by H.J. Heinz as a food technologist responsible
for product and process
development, and has consulted
for the food and
pharmaceutical industries.
Whilst there are many applications
for vision in the
pharmaceutical industry throughout the manufacturing process, more recently there has been a lot of
developments with regard to packaging inspection.
For businesses that rely on innovation, like the UK's
pharmaceutical industry, intellectual property — and more specifically, patents — are a crucial driving force in fuelling research and
development.
In medicine today, physician - scientists and basic scientists supplement support
for their research by applying their expertise part time to develop and test commercial products.1 In my own field, vision science, university - based researchers obtain additional funding through clinical and electrophysiologic studies, pathology, imaging, biochemistry, and animal model
development performed
for pharmaceutical and instrument companies.
Gray was the 1999 recipient of the
Pharmaceutical Care Award of the
Pharmaceutical Journal and Glaxo Wellcome UK
for excellence in the
development of
pharmaceutical services.
«Big pharma has been fairly resilient, with
pharmaceutical firms continuing to hire
for drug
development.
So
for a lot of reasons, the pipeline of
development that the
pharmaceutical companies had
for developing new kinds of antibiotics really slowed down.
Most carried out no
development,» says Barry O'Dowd, IDA Ireland's manager
for pharmaceuticals and biotechnology.
The ability to work well in a team is the No. 1 skill that industry employers look
for, says Neil Stahl, senior vice president of research and
development sciences at Regeneron
Pharmaceuticals in Tarrytown, New York.
AquaPharm aims to find novel medicinal compounds from a variety of marine sources and licence them to
pharmaceutical companies
for development.
In a new study, published in International Journal of Pharmaceutics, the researchers show that the extremely porous magnesium carbonate Upsalite may provide a great potential
for the
development of new drug formulations of active
pharmaceutical ingredients with poor aqueous solubility.
This is what is known as idiosyncratic toxicity and is a big headache
for the
pharmaceutical industry, as it tends to be detected in late
development stages of the drug and even when it is already on the market, often causing the drug to be withdrawn.
In a study being published in the journal Neuron, researchers show that the signal molecule TGF - beta acts as a time signal that regulates the nerve stem cells» potential at different stages of the brain's
development — knowledge that may be significant
for future
pharmaceutical development.
Researchers can now freeze biomolecules mid-movement and visualise processes they have never previously seen, which is decisive
for both the basic understanding of life's chemistry and
for the
development of
pharmaceuticals.
Even though business
development roles within the
pharmaceutical industry are definitely something I am also considering, an MBA course is a very expensive option to get relevant business training.I've also talked to a friend who works
for the management consulting and technology services company Accenture, who then introduced me to a recruitment agency which specialises in business
development.
«Our data provides a strong rationale
for further
development and optimization of RIPK2 - targeted
pharmaceuticals and diagnostics.»
Today the brain's serotonin system is already a known target
for the treatment of depression, and according to researchers it should be possible to use time signals in
pharmaceutical development based on stem cells.
Bristol - Myers Squibb won its citation «
for extending and enhancing human life through innovative
pharmaceutical research and
development, and
for redefining the science of clinical study through groundbreaking and extremely complex clinical trials that are now recognized as industry models.»
Among the interesting topics covered in Pathways are: the changing role of the patient in the total health equation and the ways in which decentralized information is affecting their expectations and demands; the dearth of pipeline products among international
pharmaceutical companies against a backdrop of increased research and
development spending; the dynamics of emerging markets and their rising demand
for therapies in chronic disease; the value of drugs and biotechnology solutions within the context of global economic realities.
Researchers said that this predictive model would be extremely useful
for pharmaceutical companies during the drug
development stage.
The research, published in The Journal of Biological Chemistry, has important implications
for diet and in the
development of new
pharmaceuticals from plant natural products.
Now a $ 60 billion market
for the biotechnology and
pharmaceutical sectors, growth of the market has been hampered by high
development costs of producing these in animal cell systems, which when factoring in a long period
for manufacturing, R&D and clinical trials, may reach around $ 1 billion per each therapeutic candidate.
The practical uses
for these methods range from the optimization of alternative energy technologies to the
development of
pharmaceuticals.
But this also provides ample time
for chlorine to interact with
pharmaceuticals that may be in the water, encouraging
development of new antibiotic compounds.
The
Pharmaceuticals Manufacturers Association says that Clinton's draft plan will «undermine incentives
for pharmaceutical research and
development».
The standard
pharmaceutical development path
for products that target pathogens moves slowly from studying safety, dosing, and biological responses in hundreds of people to an expensive efficacy trial with thousands of participants at high risk of becoming naturally infected.
Baroness Chalker, the Minister
for Overseas
Development, tells me she welcomes closer collaboration between the
pharmaceuticals industry, the WHO, and aid donors.
«We may not have the information to know whether it's really safe
for the general population,» including children, the elderly, the sick or pregnant women, says chemist Richard Sachleben, who works in
pharmaceutical research and
development.
The vaccine technology clearly has a biological effect that prevents dengue,» says Derek Wallace, regional director of clinical
development for Sanofi Pasteur, the French
pharmaceutical firm developing the vaccine, who reported results online today at The Lancet.
«The
development of this microfluidic lung model, as well as other organs - on - chip, holds the promise of improving the physiological relevance of cellular models
for more accurate prediction of the effects of toxicants and drugs on humans, and
for reducing the use of animals in medical and
pharmaceutical research,» said Sonia Grego, Ph.D., research scientist at RTI and the project's principal investigator.
Rothstein has launched a collaboration with California - based Isis
Pharmaceuticals to pursue the
development of a drug that could do the same
for patients with ALS and FTD.
About VentiRx VentiRx
Pharmaceuticals Inc. is a clinical stage biopharmaceutical company committed to the
development and commercialization of novel Toll - like receptor 8 (TLR8) immunotherapies
for the treatment of cancer, respiratory and inflammatory diseases.